208 related articles for article (PubMed ID: 6370974)
1. Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
Feighner JP; Merideth CH; Claghorn JL
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):47-51. PubMed ID: 6370974
[TBL] [Abstract][Full Text] [Related]
2. Double-blind placebo-controlled multicenter evaluation of the efficacy and safety of nomifensine in depressed outpatients.
Goldstein BJ; Brauzer B; Kentsmith D; Rosenthal S; Charalampous KD
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):52-5. PubMed ID: 6370975
[TBL] [Abstract][Full Text] [Related]
3. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
Cohn JB; Varga L; Lyford A
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of the efficacy and safety of nomifensine maleate vs. placebo in depressed outpatients.
Georgia EH
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):43-6. PubMed ID: 6232263
[TBL] [Abstract][Full Text] [Related]
5. Nomifensine in geriatric inpatients: a placebo-controlled study.
Jansen W; Siegfried K
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):63-7. PubMed ID: 6370979
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
Merideth CH; Feighner JP; Hendrickson G
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
[TBL] [Abstract][Full Text] [Related]
7. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
[TBL] [Abstract][Full Text] [Related]
8. Nomifensine in the treatment of depressed geriatric patients.
Goldstein SE; Birnbom F; Laliberte R
J Clin Psychiatry; 1982 Jul; 43(7):287-9. PubMed ID: 7045090
[TBL] [Abstract][Full Text] [Related]
9. Nomifensine vs. imipramine in depressed inpatients.
Fann WE; Lyle FA; Higginbotham W
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
[TBL] [Abstract][Full Text] [Related]
10. Pooling 12 nomifensine studies for efficacy generalizability.
Gillings D; Grizzle J; Koch G; Rickels K; Amara I; Donelan M; Hardiman S; Nash R; Sollecito W; Stager W
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):78-84. PubMed ID: 6370982
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of nomifensine in different depressive syndromes.
Overall JE
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):85-8. PubMed ID: 6370983
[TBL] [Abstract][Full Text] [Related]
12. A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
Fabre LF; Putman HP
J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176
[TBL] [Abstract][Full Text] [Related]
13. An overview of side effects and long-term experience with nomifensine from United States clinical trials.
Yakabow AL; Hardiman S; Nash RJ
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):96-101. PubMed ID: 6370985
[TBL] [Abstract][Full Text] [Related]
14. [Study of nomifensine in the treatment of depressive states (author's transl)].
Zermatten A; Cumps J
Acta Psychiatr Belg; 1981; 81(4):379-98. PubMed ID: 7036657
[TBL] [Abstract][Full Text] [Related]
15. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia.
Mendels J; Kiev A; Fabre LF
Depress Anxiety; 1999; 9(2):54-60. PubMed ID: 10207659
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of diclofensine with nomifensine in outpatients with dysphoric mood.
Funke HJ; Holtmann W; Ismail S; Jansen W; Leonhardt KF; Muth H; Omer LM; O'Connolly M; Ramm H
Pharmacopsychiatry; 1986 May; 19(3):120-3. PubMed ID: 3725890
[TBL] [Abstract][Full Text] [Related]
18. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]